Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Health and Human Services, Department of, National Institutes of Health
The official notice is always free. Read the full documents there before you bid.
Key facts
- Closes
- Nov 30, 2026, 11:00 AM ET (9 days left)
- Place of work
- Bethesda, Maryland
- Notice type
- Sources soughtThe agency is checking which businesses could do the work. It is not a request for a bid.
- Solicitation number
- 75N98027R00020
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Posted
- Nov 16, 2026
- Codes
- NAICS 325411 | PSC AN11
- Contact in the notice
- Polina Klimenkova, polina.klimenkova@nih.gov
- Source
- SAM.gov Contract Opportunities
What this is
A plain-English summary has not been written for this notice yet. The facts above come straight from the notice, and the original description is further down this page.
Similar open bids
Blanket Purchase Agreement for Medical Gases and Dry Ice
Dept of Defense · Silver Spring, Maryland
2 days leftCombined synopsis and solicitationSmall business set-asideCloses Nov 23, 2026, 11:00 AM ET
Storage and monitoring of ManNac for FDA regulations
Health and Human Services, Department of · Bethesda, Maryland
5 days leftPresolicitationCloses Nov 26, 2026, 9:00 AM ET
Notice of Intent to Sole Source - Werfen USA LLC - ACL TOP 750 Analyzers kits and reagents
Health and Human Services, Department of · Bethesda, Maryland
6 days leftPresolicitationCloses Nov 27, 2026, 12:00 PM ET
Intent to Sole Source - TELEMED ArtUs EXT-2H ultrasound system with RF module, two ultrasound transducers, and a ProbeFix Dynamic T probe holder
Health and Human Services, Department of · Bethesda, Maryland
10 days leftPresolicitationCloses Dec 1, 2026, 12:00 PM ET
X-Ray Computed Tomography Cabinet System (Revised Requirements)
Dept of Defense · Patuxent River, Maryland
16 days leftCombined synopsis and solicitationCloses Dec 7, 2026, 12:00 PM ET
Recent awards from Health and Human Services, Department of
Award notices this agency published, as listed by the source.
- Health and Human Services, Department of · awarded Nov 19, 2026 · US$405,099 · to RED HERITAGE MEDICAL LLC Arab AL 35016 USA
- Health and Human Services, Department of · awarded Nov 19, 2026 · US$2,000,000 · to SANOFI VACCINES US INC. Swiftwater PA 18370 USA
- Health and Human Services, Department of · awarded Nov 13, 2026 · US$26,593 · to DT-TRAK CONSULTING, INC. Miller SD 57362 USA
- Health and Human Services, Department of · awarded Nov 12, 2026 · US$48,000,000 · to UNIVERSITY OF SASKATCHEWAN Saskatoon SK S7N 5A2 CAN
Original description from the notice
Title: Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. The Government is especially interested in determining (1) the availability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition (5) commercial product and services availability. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. Background: The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) conducts translational research in the area of human therapeutics development by moving small molecule and biologic drug candidates forward in the drug development pipeline. Upon reaching predetermined milestones, TDB hands off clinical candidates to external partners to bring these novel therapies to patients. In addition to developing new candidate drugs, TDB seeks to advance the entire field of drug discovery and development by encouraging scientific and technological innovations aimed at improving success rates in the crucial preclinical stage of drug development. The TDB model is to operate as a comprehensive small molecule and biologics drug development organization, moving therapeutic candidates through each phase of the preclinical development process until an Investigational New Drug (IND) application is filed with the US Food and Drug Administration (FDA). TDB conducts drug development as collaborations, with therapeutic candidates originating from academia, industry, non- profit foundations, or internally from NCATS and other NIH Institutes and Centers. TDB’s operational strategy is to combine the capabilities of in-house staff and collaborative partners with complementary support from contract research organizations (CROs). Each development program operates in a multi-disciplinary matrix team environment, with NCATS responsible for the overall planning and execution. Please see the attachment for more details.
Source: SAM.gov, General Services Administration (public domain). BidTerrier shows public notices as published and cannot confirm that a notice is complete or current. Details can change, so always check the official notice. Nothing here says whether your business is eligible.